Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY-NCJournal of biochemical and molecular toxicology

LncRNA A1BGAS1 Serves as a Tumor Suppressor in Non-Small Cell Lung Cancer by Modulating the Expression of miR-3942-5P.

  1. 1Department of Thoracic Surgery, Linyi People's Hospital, Linyi, China.
  2. 2Internal Medicine Department, Ward 1, Linyi Cancer Hospital, Linyi, China.
  3. 3Department of Surgery, Yinan County ShuangHou Town Health Center, Linyi, China.

Abstract

Non-small cell lung cancer (NSCLC), the leading contributor to global cancer mortality, is associated with a notably unfavorable prognosis. This study aims to explore the regulatory interaction between A1BG-AS1 and miR-3942-5p and its molecular mechanisms. The level of A1BG-AS1 and miR-3942-5p in both tumor tissues and cell lines (BEAS-2B, A549, H226) were measured using qPCR. Functional effects of A1BG-AS1 overexpression in NSCLC cells were evaluated through CCK-8, flow cytometry, and Transwell assays. The interaction between A1BG-AS1 and miR-3942-5p was validated through dual-luciferase reporter assays and rescue studies. A1BG-AS1 expression was markedly reduced in both NSCLC tissues and cell lines. A1BG-AS1 expression was significantly associated with various clinical parameters. Overexpression of A1BG-AS1 suppressed NSCLC cell function. Mechanistically, A1BG-AS1 interacted with and negatively regulated miR-3942-5p, and the antitumor effects of A1BG-AS1 overexpression were reversed by miR-3942-5p mimics.A1BG-AS1 inhibits NSCLC tumor progression by targeting miR-3942-5p.

Related

  1. LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer
    Ke Yin, Yi Li, Mengying Tang
    HereditasPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Investigating long non-coding RNA (lncRNA) HOTAIR expression changes in ischemic stroke patients.
    Alia Saberi, Niloufar Nabavi, Amirreza Ghayeghran +6
    BMC research notesPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
  3. Differential LncRNA expression profile in the plasma of preeclampsia and normal pregnancies
    L. Peng, W. Lai, J. Huang +1
    bioRxivPreprintCC BYFull textPhysiologybioRxiv
  4. Zhuyu pill relieves cholestasis in rats by modulating the expression of lncRNAs and circRNAs
    Fenghua Zhang, Rui Cheng, Zhili Zheng +3
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. A Pre-post Rehabilitation Study of Exosomal mRNA and lncRNA Expression Profiles Reveals Potential Role of UBE2G1 in Rehabilitation of Parkinson’s Disease
    Yixuan Wang, Yonghong Liu, Boyan Fang +4
    Journal of Central Nervous System DiseasePeer-reviewedCC BYFull textNeurologyDOAJ
BibTeX
@article{du2026lncrna,
  title = {{LncRNA A1BGAS1 Serves as a Tumor Suppressor in Non-Small Cell Lung Cancer by Modulating the Expression of miR-3942-5P.}},
  author = {Jiahui Du and Zhenhua Li and Chunqiang Wang and Xuexi Zhang},
  journal = {Journal of biochemical and molecular toxicology},
  year = {2026},
  month = oct,
  doi = {10.1002/jbt.71151},
  url = {https://europepmc.org/article/MED/42952240},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - LncRNA A1BGAS1 Serves as a Tumor Suppressor in Non-Small Cell Lung Cancer by Modulating the Expression of miR-3942-5P.
AU  - Jiahui Du
AU  - Zhenhua Li
AU  - Chunqiang Wang
AU  - Xuexi Zhang
PY  - 2026
DA  - 2026/10/28
JO  - Journal of biochemical and molecular toxicology
DO  - 10.1002/jbt.71151
UR  - https://europepmc.org/article/MED/42952240
AB  - Non-small cell lung cancer (NSCLC), the leading contributor to global cancer mortality, is associated with a notably unfavorable prognosis. This study aims to explore the regulatory interaction between A1BG-AS1 and miR-3942-5p and its molecular mechanisms. The level of A1BG-AS1 and miR-3942-5p in both tumor tissues and cell lines (BEAS-2B, A549, H226) were measured using qPCR. Functional effects of A1BG-AS1 overexpression in NSCLC cells were evaluated through CCK-8, flow cytometry, and Transwell assays. The interaction between A1BG-AS1 and miR-3942-5p was validated through dual-luciferase reporter assays and rescue studies. A1BG-AS1 expression was markedly reduced in both NSCLC tissues and cell lines. A1BG-AS1 expression was significantly associated with various clinical parameters. Overexpression of A1BG-AS1 suppressed NSCLC cell function. Mechanistically, A1BG-AS1 interacted with and negatively regulated miR-3942-5p, and the antitumor effects of A1BG-AS1 overexpression were reversed by miR-3942-5p mimics.A1BG-AS1 inhibits NSCLC tumor progression by targeting miR-3942-5p.
SN  - 1095-6670
SN  - 1099-0461
ER  -